You are here

APHL/CDC Fellowships

Open until filled. Newborn Screening Bioinformatics Fellowship Program

APHL - CDC Program Description

"Newborn Screening programs are faced with new challenges due to the expansion in the number of newborn screening diseases together with the adoption of more sophisticated biochemical and molecular technologies used to improve disease detection for newborns with heritable diseases.

These challenges include accurate interpretation of complex biomarker profiles, development of analytic and interpretative tools for genetic testing and effective approaches for laboratory data management. In addition there is a need for harmonization of results across complex testing platforms that would greatly aid in biomarker result interpretation.

To address this unmet need in newborn screening laboratories, APHL, in collaboration with the CDC​ Newborn Screening and Molecular Biology Branch​, is offering exciting fellowship opportunities for graduates of bioinformatics programs. This fellowship aims to train and prepare bioinformaticians to apply their expertise within public health and design tools to aid existing public health personnel in the use of bioinformatics. Its mission is to provide a high quality training experience for fellows while providing workforce capacity to the public health laboratory community."

To apply, email the following to michele.caggana@health.ny.gov:

  • Application
  • Narrative describing your relevant experience and why you are applying for the fellowship
    • Not to exceed one single spaced page
  • Resume or CV
    • Not to exceed 2 pages
  • Three letters of recommendation
  • Official transcripts

Stipend (paid by APHL):

  • PhD-level fellows - $65,448 plus an additional $500 monthly insurance stipend.
  • Master’s-level fellows - $54,095 plus an additional $500 monthly insurance stipend.

 




Additional APHL – CDC Fellowships

Check back for information on new fellowships in the area of infectious disease, environmental health and newborn screening coming soon.